BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26024430)

  • 1. Relationship between serum DHEAS and oxidative stress levels of body mass index in healthy postmenopausal women.
    Goy B; Atmaca M; Aslan M; Ucler R; Alay M; Seven I; Demir H; Ozturk M
    Redox Rep; 2016 Mar; 21(2):61-6. PubMed ID: 26024430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
    Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
    J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of serum leptin levels in healthy postmenopausal women.
    Lambrinoudaki I; Christodoulakos G; Panoulis C; Botsis D; Rizos D; Augoulea A; Creatsas G
    J Endocrinol Invest; 2003 Dec; 26(12):1225-30. PubMed ID: 15055477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of dehydroepiandrosterone sulfate, body composition, and physical fitness in independent community-dwelling older men and women.
    Abbasi A; Duthie EH; Sheldahl L; Wilson C; Sasse E; Rudman I; Mattson DE
    J Am Geriatr Soc; 1998 Mar; 46(3):263-73. PubMed ID: 9514370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of age on serum dehydroepiandrosterone sulfate, IGF-I, and IL-6 levels in women.
    Haden ST; Glowacki J; Hurwitz S; Rosen C; LeBoff MS
    Calcif Tissue Int; 2000 Jun; 66(6):414-8. PubMed ID: 10821876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an Italian study on healthy free-living over-ninety-year-olds.
    Ravaglia G; Forti P; Maioli F; Boschi F; Bernardi M; Pratelli L; Pizzoferrato A; Gasbarrini G
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1173-8. PubMed ID: 8772596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP3A7*1C polymorphism, serum dehydroepiandrosterone sulfate level, and bone mineral density in postmenopausal women.
    Bácsi K; Kósa JP; Borgulya G; Balla B; Lazáry A; Nagy Z; Horváth C; Speer G; Lakatos P
    Calcif Tissue Int; 2007 Mar; 80(3):154-9. PubMed ID: 17334880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid sulfatase activity in subcutaneous and visceral adipose tissue: a comparison between pre- and postmenopausal women.
    Paatela H; Wang F; Vihma V; Savolainen-Peltonen H; Mikkola TS; Turpeinen U; Hämäläinen E; Jauhiainen M; Tikkanen MJ
    Eur J Endocrinol; 2016 Feb; 174(2):167-75. PubMed ID: 26553725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular mass index and ventricular septum thickness are associated with serum dehydroepiandrosterone-sulphate levels in hypertensive women.
    Szathmári M; Treszl A; Vásárhelyi B
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):110-4. PubMed ID: 12807512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical markers of bone remodeling correlate negatively with circulating TSH in postmenopausal women.
    Zofkova I; Hill M
    Endocr Regul; 2008 Sep; 42(4):121-7. PubMed ID: 18999899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
    Dorgan JF; Stanczyk FZ; Longcope C; Stephenson HE; Chang L; Miller R; Franz C; Falk RT; Kahle L
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):177-81. PubMed ID: 9138660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
    Vermeulen A; Kaufman JM; Giagulli VA
    J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on relationship between endogenous androgens and insulin resistance at the different stages of postmenopause].
    Cao YK; Zhang SF; Zou SE; Xia X; Xu LN
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):740-4. PubMed ID: 24406129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: the Rancho Bernardo Study.
    Barrett-Connor E; Ferrara A
    J Clin Endocrinol Metab; 1996 Jan; 81(1):59-64. PubMed ID: 8550794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition.
    Burger HG; Dudley EC; Cui J; Dennerstein L; Hopper JL
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2832-8. PubMed ID: 10946891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer size in postmenopausal women is correlated with body mass index and androgen serum levels.
    Asseryanis E; Ruecklinger E; Hellan M; Kubista E; Singer CF
    Gynecol Endocrinol; 2004 Jan; 18(1):29-36. PubMed ID: 15106362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of ischemia modified albumin in overweight/obese postmenopausal women: a potential biomarker of atherosclerotic burden associated with oxidative stress.
    Kazanis K; Dalamaga M; Kassi E; Nounopoulos C; Manolis AS; Merantzi G; Jullien G; Dionyssiou-Asteriou A
    Maturitas; 2011 Oct; 70(2):182-7. PubMed ID: 21839592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of progesterone and DHEAS serum levels to 5-HT1A receptor binding potential in pre- and postmenopausal women.
    Stein P; Baldinger P; Kaufmann U; Christina RM; Hahn A; Höflich A; Kranz GS; Savli M; Wadsak W; Mitterhauser M; Winkler D; Kasper S; Lanzenberger R
    Psychoneuroendocrinology; 2014 Aug; 46():52-63. PubMed ID: 24882158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism.
    Földes J; Lakatos P; Zsadányi J; Horváth C
    Eur J Endocrinol; 1997 Mar; 136(3):277-81. PubMed ID: 9100552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.